Alaunos Therapeutics director receives 21,829 shares

Separate reported positions include 62,416 shares held by WaterMill Asset Management Corp. and 24 shares in Postma's spouse's IRA.

Rhea-AI Filing Summary

Alaunos Therapeutics, Inc. (TCRT) director Robert W. Postma acquired 21,829 common shares on October 6, 2026; the shares were issued in lieu of board fees. The transaction reports a per-share amount of $0.7444. Postma's reported direct holdings after the acquisition were 80,438 shares. Separate reported positions were 24 shares held by his spouse's IRA and 62,416 shares held by WaterMill Asset Management Corp., where Postma serves as principal.

Insider Trade Summary

Grant/Award: 21,829 shares

Grant/Award 3 txns

Insider Postma Robert W

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock F1	21,829	$0.7444	$16K
holding	Common Stock	--	--	--
holding	Common Stock F2	--	--	--

Holdings After Transaction: Common Stock — 80,438 shares (Direct); Common Stock — 24 shares (Indirect, By spouse's IRA); Common Stock — 62,416 shares (Indirect, By WaterMill Asset Management Corp.(2))

Footnotes (2)

1. F1. Represents shares of common stock issued in lieu of board fees.
2. F2. The shares are directly held by WaterMill Asset Management Corp. ("WaterMill"). The Reporting Person serves as the principal of WaterMill

Key Figures

Common shares acquired: 21,829 shares Reported per-share amount: $0.7444 per share Postma's direct holdings after acquisition: 80,438 shares +2 more

5 metrics

Common shares acquired 21,829 shares October 6, 2026; issued in lieu of board fees

Reported per-share amount $0.7444 per share For the share issuance on October 6, 2026

Postma's direct holdings after acquisition 80,438 shares Reported after the October 6, 2026 acquisition

Shares held by spouse's IRA 24 shares Indirect holding reported on October 6, 2026

Shares held by WaterMill Asset Management Corp. 62,416 shares Indirect holding reported on October 6, 2026; Postma serves as the entity's principal

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many shares did Alaunos Therapeutics (TCRT) director Robert W. Postma receive?

Robert W. Postma, a director of Alaunos Therapeutics (TCRT), acquired 21,829 common shares on October 6, 2026, issued in lieu of board fees. The reported per-share amount was $0.7444. His reported direct holdings after the acquisition were 80,438 shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/08/2026 - 04:30 PM Accepted by SEC EDGAR 10/08/2026 - 04:30 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Postma Robert W

(Last) (First) (Middle)

501 E LAS OLAS BLVD

SUITE 300

(Street)

FORT LAUDERDALE FLORIDA 33301

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Alaunos Therapeutics, Inc. [ TCRT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
10/06/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	10/06/2026		A		21,829(1)	A	$0.7444	80,438	D
Common Stock								24	I	By spouse's IRA
Common Stock								62,416(2)	I	By WaterMill Asset Management Corp.(2)(2)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares of common stock issued in lieu of board fees.

2. The shares are directly held by WaterMill Asset Management Corp. ("WaterMill"). The Reporting Person serves as the principal of WaterMill

	Postma Robert W	10/08/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)